Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Study subject details

From: Auto-antibodies against carbonyl-modified vimentin in COPD: potential role as a biomarker

 

Age

M/F

Pack years

FEV1/FVC

% pred FEV1

NS

50 ± 3

10/4

0

0.97 ± 0.03

101 ± 3

Smoker

60 ± 9

14/9

27 ± 16

0.81 ± 0.03

86 ± 3

COPD 21 ex-smokers

5 smokers

70 ± 6

16/10

47 ± 32

0.41 – 0.66

40—88

  1. Data are depicted as Mean ± SD for age and pack years. FEV1/FVC and % pred FEV1 are displayed as Mean ± SEM,. FEV1/FVC ratio is pre-bronchodilator
  2. Abbreviations: pred predicted, M male, F Female, FEV1 Forced expiratory volume in 1 s, FVC Forced vital capacity, NS Non-smoker
Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us